Skip to main content

Solarea Bio

Cambridge, United States

Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.

$9.9M raised
Nov 2025
Venture - Series Unknown

Top Investors

S2G InvestmentsViking Global InvestorsRising TideNational Institute on AgingBold Capital Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Solarea Bio

How much funding has Solarea Bio raised?
Solarea Bio has raised $9.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Who are Solarea Bio's investors?
Solarea Bio's investors include S2G Investments, Viking Global Investors, Rising Tide, National Institute on Aging, Bold Capital Partners.
Where is Solarea Bio headquartered?
Solarea Bio is headquartered in Cambridge, United States.
What does Solarea Bio do?
Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
What stage is Solarea Bio at?
Solarea Bio is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Solarea Bio — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/solarea-bio. Accessed June 4, 2026.
APA
VCBacked. (2025). Solarea Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/solarea-bio
Wikipedia (cite web)
{{cite web |title=Solarea Bio — Funding & Investors |url=https://www.vcbacked.co/company/solarea-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .